<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04356976</url>
  </required_header>
  <id_info>
    <org_study_id>VPatchPriRCT</org_study_id>
    <nct_id>NCT04356976</nct_id>
  </id_info>
  <brief_title>Ventralex vs Stratafix for Primary Ventral Hernias</brief_title>
  <acronym>VPatchPriRCT</acronym>
  <official_title>Randomised Controlled Trial of Ventralex Hernia Patch Versus Stratafix Suture for Midline Primary Ventral Hernias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised controlled trial comparing Ventralex Hernia Patch with Stratafix suture for repair
      of primary ventral hernias in the midline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary hernias in the midline, including umbilical hernias and epigastric hernias, are among
      the most common conditions requiring surgery.

      Mesh-reinforced as well as suture repair are used for the treatment of primary hernias, but
      for smaller umbilical hernias (diameter 1-3cm), there is little evidence for the superiority
      of mesh repair. Despite the widely use of composite ventral patch, there are few studies
      showing the advantage and disadvantage of ventral patch. In recent years, the barbed suture
      has been widely used in umbilical and incisional hernias, in laparoscopic as well as in open
      surgery. However, there are no studies comparing ventral patch with slowly absorbable barbed
      suture in open surgery.

      The investigators intend to compare the use of sublay composite mesh (ventral-patch) with
      non-resorbable barbed prolene suture repair only and investigate recurrence rate and other
      short and long-term postoperative complications in these two methods.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled trial comparing Ventralex hernia patch with Stratafix sutures for repair of primary ventral hernias</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The patient and the staff responsible for the postoperative care of the patient will be masked for the allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hernia recurrence</measure>
    <time_frame>One year</time_frame>
    <description>Recurrence diagnosed at clinical and/or radiologic examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of intra-and postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications occurring intraoperatively or in the postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of seroma development</measure>
    <time_frame>one year</time_frame>
    <description>Seroma confirmed at follow-up examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persisting pain</measure>
    <time_frame>One year</time_frame>
    <description>Postoperative pain rated with the Ventral Hernia Pain Questionnaire. Pain rated on a scale from 1 to 7, with higher scores indicating more severe pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of days postoperative sick leave</measure>
    <time_frame>30 days</time_frame>
    <description>Postoperative sick leave</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Ventralex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repair with Ventralex hernia patch in sublay position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stratafix</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Repair with Stratafix suture</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ventralex</intervention_name>
    <description>Repair of hernia using Ventralex patch in sublay position</description>
    <arm_group_label>Ventralex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stratafix</intervention_name>
    <description>Repair of hernia without mesh. Defect closed with Stratafix suture.</description>
    <arm_group_label>Stratafix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Defect 1-4 cm

          -  Primary ventral hernia in the midline

          -  BMI&lt;35

        Exclusion Criteria:

          -  Defect &gt;4cm

          -  BMI&gt;35

          -  Recurrent hernia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel Sandblom, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel Sandblom, MD, PhD</last_name>
    <phone>+4686162362</phone>
    <email>gabriel.sandblom@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Asmatullah Katawazai, MD</last_name>
    <phone>+4658666000</phone>
    <email>asmatullah.katawazai@regionorebrolan.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karlskoga Hospital</name>
      <address>
        <city>Karlskoga</city>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Asmatullah Katawazai, MD</last_name>
      <phone>+4658666000</phone>
      <email>asmatullah.katawazai@regionorebrolan.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 19, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2020</study_first_posted>
  <last_update_submitted>April 21, 2020</last_update_submitted>
  <last_update_submitted_qc>April 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Gabriel Sandblom</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

